Improved recombinant protein production in E. coli

enGenes Biotech has developed its unique enGenes-eXpress™ proprietary technology platform for outstanding recombinant protein production in Escherichia coli (E.coli). -eXpress uses an advanced growth decoupled mechanism platform that allows customers to achieve customized solutions for the cost-effective production of recombinant proteins in microbial expression systems.

The technology is leveraged from enGenes’ world-class experience in cutting-edge genetic engineering, combined with a broad expertise in bioprocess engineering, to produce a range of best-in-class protein expression systems.

For more information follow https://www.pharmaceutical-networking.com/improved-recombinant-protein-production-in-e-coli/